Latest news
Seaport Therapeutics, Inc. (NASDAQ:SPTX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeatMarketBeat · Sun, 09 Aug 2026 08:27:42 GMTTop Seaport Therapeutics (SPTX) Competitors 2026 - MarketBeatMarketBeat · Sat, 08 Aug 2026 08:21:53 GMTSeaport Therapeutics (NASDAQ:SPTX) Sets New 52-Week High - Time to Buy? - MarketBeatMarketBeat · Fri, 07 Aug 2026 01:59:38 GMTSeaport Therapeutics (SPTX): Daphne Zohar discloses 5.23M-share, 9.1% beneficial stake - Stock TitanStock Titan · Wed, 05 Aug 2026 12:06:40 GMTSeaport Therapeutics (SPTX) insider Steven M. Paul reports 6.3% stake - Stock TitanStock Titan · Wed, 05 Aug 2026 10:05:10 GMTSeaport Therapeutics (SPTX) 10K Form and Latest SEC Filings 2026 - MarketBeatMarketBeat · Wed, 05 Aug 2026 07:00:00 GMTSeaport Therapeutics (NASDAQ:SPTX) Given Buy Rating at HC Wainwright - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:50:22 GMTSeaport Therapeutics 2Q Research and Development Expenses Were $24.6M >SPTX - MoomooMoomoo · Mon, 03 Aug 2026 11:42:02 GMT